Inhibition of mouse mammary tumor virus-induced T cell responses in vivo by antibodies to an open reading frame protein

doi:10.1084/jem.176.6.1769

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Acha-Orbea, H.
	Articles by MacDonald, H. R.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Acha-Orbea, H.
	Articles by MacDonald, H. R.


Social Bookmarking

	What's this?

ARTICLES

Inhibition of mouse mammary tumor virus-induced T cell responses in vivo by antibodies to an open reading frame protein

H Acha-Orbea, L Scarpellino, AN Shakhov, W Held and HR MacDonald
Ludwig Institute for Cancer Research, Lausanne Branch, Epalinges, Switzerland.

Minor lymphocyte stimulating (Mls) antigens specifically stimulate T cell responses that are restricted to particular T cell receptor (TCR) beta chain variable domains. The Mls phenotype is genetically controlled by an open reading frame (orf) located in the 3' long terminal repeat of mouse mammary tumor virus (MMTV); however, the mechanism of action of the orf gene product is unknown. Whereas predicted orf amino acid sequences show strong overall homology, the 20- 30 COOH-terminal residues are strikingly polymorphic. This polymorphic region correlates with TCR V beta specificity. We have generated monoclonal antibodies to a synthetic peptide encompassing the 19 COOH- terminal amino acid residues of Mtv-7 orf, which encodes the Mls-1a determinant. We show here that these antibodies block Mls responses in vitro and can interfere specifically with thymic clonal deletion of Mls- 1a reactive V beta 6+ T cells in neonatal mice. Furthermore, the antibodies can inhibit V beta 6+ T cell responses in vivo to an infectious MMTV that shares orf sequence homology and TCR specificity with Mtv-7. These results confirm the predicted extracellular localization of the orf COOH terminus and imply that the orf proteins of both endogenous and exogenous MMTV interact directly with TCR V beta.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Mpandi, M., Otten, L. A., Lavanchy, C., Acha-Orbea, H., Finke, D. (2003). Passive Immunization with Neutralizing Antibodies Interrupts the Mouse Mammary Tumor Virus Life Cycle. J. Virol. 77: 9369-9377 [Abstract] [Full Text]
Baribaud, F., Wirth, S., Maillard, I., Valsesia, S., Acha-Orbea, H., Diggelmann, H. (2001). Identification of Key Amino Acids of the Mouse Mammary Tumor Virus Superantigen Involved in the Specific Interaction with T-Cell Receptor V{beta} Domains. J. Virol. 75: 7453-7461 [Abstract] [Full Text]
Velin, D., Fotopoulos, G., Kraehenbuhl, J.-P., Acha-Orbea, H. (1999). Systemic Antibodies Can Inhibit Mouse Mammary Tumor Virus-Driven Superantigen Response in Mucosa-Associated Lymphoid Tissues. J. Virol. 73: 1729-1733 [Abstract] [Full Text]
Astori, M, Karapetian, O (1998). Antibodies to the C-terminal dipeptide of mouse mammary tumor virus [MMTV(SW)] superantigen effectively inhibit T-cell activation in vivo. J. Gen. Virol. 79: 57-60 [Abstract]
Delcourt, M., Thibodeau, J., Denis, F., Sekaly, R.-P. (1997). Paracrine Transfer of Mouse Mammary Tumor Virus Superantigen. JEM 185: 471-480 [Abstract] [Full Text]